Alprazolam Tapering Guidelines

Introduction to Tapering

• The Centers for Disease Control and Prevention recommends reducing the dose of alprazolam by 0.25 mg every 1-2 weeks, representing a 12.5% reduction per step, until complete discontinuation for a patient taking 2 mg daily 1, 2

Initial Taper Strategy

• The Mayo Clinic suggests reducing one dose from 1 mg to 0.75 mg while maintaining the other at 1 mg, or reducing both doses proportionally, such as 0.875 mg twice daily 3

Critical Safety Considerations

• The Centers for Disease Control and Prevention warns that abrupt discontinuation of alprazolam must be avoided, as it can cause rebound anxiety, hallucinations, seizures, delirium tremens, and rarely death 1, 2

Managing Withdrawal Symptoms

• The Mayo Clinic recommends using adjuvant medications liberally to prevent and treat withdrawal symptoms, including clonidine, tizanidine, lofexidine, gabapentin, trazodone, mirtazapine, or tricyclic antidepressants for short-term use 3, 5
• The Mayo Clinic also suggests using loperamide for gastrointestinal symptoms, but with caution due to the risk of abuse 5

Alternative Approach: Slower Taper

• The Centers for Disease Control and Prevention recommends reducing the dose by 10% of the current dose every 1-2 weeks for patients who have been on alprazolam for prolonged periods or experience significant withdrawal 1, 2
• The Mayo Clinic suggests that this approach may take several months but reduces withdrawal severity 3, 5

Monitoring and Support

• The Mayo Clinic emphasizes the importance of close observation during taper, with clinician availability to treat symptoms and manage patient fears 6
• The Centers for Disease Control and Prevention recommends offering Cognitive Behavioral Therapy (CBT) concurrently, as it significantly increases tapering success rates 1, 2

Important Caveats

• The Mayo Clinic warns against abruptly stopping or making large dose reductions, except in extreme circumstances, and notes that the final dose reductions may be the most difficult and require slower tapering 6
• The Mayo Clinic also notes that some patients may experience protracted withdrawal symptoms, such as dysphoria, insomnia, and anhedonia, for months after complete discontinuation 3, 5